MedPath

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Conditions
Anxiety
Recurrent Fallopian Tube Carcinoma
Stage IA Fallopian Tube Cancer AJCC v6 and v7
Stage IIB Fallopian Tube Cancer AJCC v6 and v7
Stage IIC Fallopian Tube Cancer AJCC v6 and v7
Stage III Ovarian Cancer AJCC v6 and v7
Stage IV Ovarian Cancer AJCC v6 and v7
Fatigue
Nausea and Vomiting
Stage I Ovarian Cancer AJCC v6 and v7
Interventions
Procedure: Assessment of Therapy Complications
Other: Medical Chart Review
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Registration Number
NCT01372787
Lead Sponsor
Gynecologic Oncology Group
Brief Summary

This clinical trial studies the quality of life and care needs of patients with persistent or recurrent ovarian cancer, fallopian tube cancer, or peritoneal cancer. Studying quality of life in patients with cancer may help determine the effects of gynecologic cancer and may help improve the quality of life for future cancer survivors.

Detailed Description

PRIMARY OBJECTIVES:

I. To determine the prevalence and severity of patient-reported symptoms in patients with platinum-resistant ovarian, fallopian tube, and peritoneal cancers at study entry and at three and six months post-enrollment.

SECONDARY OBJECTIVES:

I. To explore the unmet needs of these women at study entry and at three and six months post-enrollment (Exploratory) II. To explore the overall quality-of-life (QOL) of these women at study entry and at three and six months post enrollment. (Exploratory) III. To explore the relationship between patient-reported symptoms and overall QOL, current cancer therapy (yes/no), and treatment responses (if on cancer therapy). (Exploratory)

OUTLINE: This is a multicenter study.

Patients complete the Needs at the End-of-Life Screening Tool (NEST), the Functional Assessment of Cancer Therapy ? Ovarian (FACT-O), the FACIT-Fatigue Subscale (FACIT-F), the National Comprehensive Cancer Network (NCCN) FACT Ovarian Symptom Index-18 (NFOSI-18), the FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort, and the FACT/GOG-Neurotoxicity (FACT/GOG-NTX) Scale quality-of-life questionnaires at baseline and at 3 and 6 months during office or clinic visits or via telephone or mail. Patients' demographic and therapy information, such as current age, ethnicity, marital status, employment status, prior chemotherapy regimens/cancer treatment, disease status (if available), performance status, patient care information, and current cancer therapy are also collected.

After completion of study participation, patients are followed up every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
103
Inclusion Criteria
  • Patients with persistent or recurrent epithelial ovarian cancer, peritoneal cancer, or fallopian tube cancer

    • Platinum-resistant (less than 6 months from date of last platinum therapy to date of first evidence of recurrent or persistent disease) disease as measured by any of the following:

      • Imaging
      • Physical exam
      • CA-125 that is twice the upper limit of normal on two occasions with at least one week apart
    • No patients who have platinum resistant or refractory disease after more than 6 months since prior therapy

  • Criteria for patients on cancer therapy (e.g., chemotherapy, non-cytotoxic regimens, hormone therapy, or radiation therapy) include recurrent or persistent disease defined as having measurable disease per RECIST (Version 1.1)

    • Patients not on chemotherapy are also eligible and are not required to have RECIST criteria
  • Life expectancy of at least 6 months

  • Patients with any performance status, yet with the ability to verbally consent and participate in the first assessment

    • Study measures will be administered in the office/clinic setting, or for study participants who are unable to attend clinics, via telephone or mail (telephone is the preferred back-up means)
  • Patients may have or have had a prior non-gynecologic malignancy within 5 years prior to study enrollment; however, they must have completed all treatments for the disease and have no evidence of disease at the time of enrollment, and ovarian, peritoneal, or fallopian tube cancer must be the primary life-threatening diagnosis

  • Patient must be able to read and write English

  • No patients receiving chemotherapy for platinum-sensitive ovarian cancer, peritoneal, or fallopian tube cancer

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Arm IAssessment of Therapy Complications-
Arm IMedical Chart Review-
Arm IQuality-of-Life Assessment-
Arm IQuestionnaire Administration-
Primary Outcome Measures
NameTimeMethod
Prevalence and severity of patient-reported symptoms as measured by the NFOSI-18, the FACIT-F subscale, and the FACT/GOG-AD and NTX subscalesUp to 6 months

Assessed at baseline, and at 3 and 6 months. The prevalence of a patient-reported symptom will be determined by the percentage of living patients reporting the presence of a symptom at the assessment time point.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (144)

Delbert Day Cancer Institute at PCRMC

🇺🇸

Rolla, Missouri, United States

Abbott-Northwestern Hospital

🇺🇸

Minneapolis, Minnesota, United States

Hennepin County Medical Center

🇺🇸

Minneapolis, Minnesota, United States

Advocate Lutheran General Hospital

🇺🇸

Park Ridge, Illinois, United States

Wayne State University/Karmanos Cancer Institute

🇺🇸

Detroit, Michigan, United States

Ascension Saint John Hospital

🇺🇸

Detroit, Michigan, United States

University of Oklahoma Health Sciences Center

🇺🇸

Oklahoma City, Oklahoma, United States

Saint Alphonsus Cancer Care Center-Boise

🇺🇸

Boise, Idaho, United States

Hartford Hospital

🇺🇸

Hartford, Connecticut, United States

Cancer Center of Kansas - Pratt

🇺🇸

Pratt, Kansas, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

Good Samaritan Regional Health Center

🇺🇸

Mount Vernon, Illinois, United States

Community Howard Regional Health

🇺🇸

Kokomo, Indiana, United States

Saint Joseph Regional Medical Center-Mishawaka

🇺🇸

Mishawaka, Indiana, United States

Michiana Hematology Oncology PC-Elkhart

🇺🇸

Elkhart, Indiana, United States

Cancer Center of Kansas - Parsons

🇺🇸

Parsons, Kansas, United States

Northern Indiana Cancer Research Consortium

🇺🇸

South Bend, Indiana, United States

Cancer Center of Kansas - Wichita

🇺🇸

Wichita, Kansas, United States

Cancer Center of Kansas - Salina

🇺🇸

Salina, Kansas, United States

Fairview Ridges Hospital

🇺🇸

Burnsville, Minnesota, United States

West Michigan Cancer Center

🇺🇸

Kalamazoo, Michigan, United States

Borgess Medical Center

🇺🇸

Kalamazoo, Michigan, United States

Saint Luke's South Hospital

🇺🇸

Overland Park, Kansas, United States

Cancer Center of Kansas - Wellington

🇺🇸

Wellington, Kansas, United States

Wichita NCI Community Oncology Research Program

🇺🇸

Wichita, Kansas, United States

Cancer Center of Kansas - Winfield

🇺🇸

Winfield, Kansas, United States

Beaumont Hospital ? Dearborn

🇺🇸

Dearborn, Michigan, United States

Genesys Regional Medical Center

🇺🇸

Grand Blanc, Michigan, United States

Maine Medical Center-Bramhall Campus

🇺🇸

Portland, Maine, United States

Baystate Medical Center

🇺🇸

Springfield, Massachusetts, United States

University of Massachusetts Memorial Health Care

🇺🇸

Worcester, Massachusetts, United States

Allegiance Health

🇺🇸

Jackson, Michigan, United States

Mercy Hospital

🇺🇸

Coon Rapids, Minnesota, United States

Saint Mary Mercy Hospital

🇺🇸

Livonia, Michigan, United States

Saint Joseph Mercy Oakland

🇺🇸

Pontiac, Michigan, United States

Lakeland Medical Center Saint Joseph

🇺🇸

Saint Joseph, Michigan, United States

Sparrow Hospital

🇺🇸

Lansing, Michigan, United States

Hutchinson Area Health Care

🇺🇸

Hutchinson, Minnesota, United States

William Beaumont Hospital-Royal Oak

🇺🇸

Royal Oak, Michigan, United States

Metro Minnesota Community Oncology Research Consortium

🇺🇸

Saint Louis Park, Minnesota, United States

Fairview-Southdale Hospital

🇺🇸

Edina, Minnesota, United States

Unity Hospital

🇺🇸

Fridley, Minnesota, United States

Minnesota Oncology Hematology PA-Maplewood

🇺🇸

Maplewood, Minnesota, United States

Saint Francis Regional Medical Center

🇺🇸

Shakopee, Minnesota, United States

Saint Dominic-Jackson Memorial Hospital

🇺🇸

Jackson, Mississippi, United States

United Hospital

🇺🇸

Saint Paul, Minnesota, United States

Regions Hospital

🇺🇸

Saint Paul, Minnesota, United States

Rice Memorial Hospital

🇺🇸

Willmar, Minnesota, United States

University of Mississippi Medical Center

🇺🇸

Jackson, Mississippi, United States

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

State University of New York Downstate Medical Center

🇺🇸

Brooklyn, New York, United States

Cancer Research for the Ozarks NCORP

🇺🇸

Springfield, Missouri, United States

Mercy Hospital Springfield

🇺🇸

Springfield, Missouri, United States

UH Seidman Cancer Center at Lake Health Mentor Campus

🇺🇸

Mentor, Ohio, United States

Main Line Health NCORP

🇺🇸

Wynnewood, Pennsylvania, United States

Atrium Health Cabarrus/LCI-Concord

🇺🇸

Concord, North Carolina, United States

Women's Cancer Center of Nevada

🇺🇸

Las Vegas, Nevada, United States

Morristown Medical Center

🇺🇸

Morristown, New Jersey, United States

Case Western Reserve University

🇺🇸

Cleveland, Ohio, United States

Lankenau Medical Center

🇺🇸

Wynnewood, Pennsylvania, United States

Oklahoma Cancer Specialists and Research Institute-Tulsa

🇺🇸

Tulsa, Oklahoma, United States

Bryn Mawr Hospital

🇺🇸

Bryn Mawr, Pennsylvania, United States

Paoli Memorial Hospital

🇺🇸

Paoli, Pennsylvania, United States

Greenville Health System Cancer Institute-Eastside

🇺🇸

Greenville, South Carolina, United States

Greenville Health System Cancer Institute-Seneca

🇺🇸

Seneca, South Carolina, United States

Scott and White Memorial Hospital

🇺🇸

Temple, Texas, United States

Avera Cancer Institute

🇺🇸

Sioux Falls, South Dakota, United States

Memorial Hermann Texas Medical Center

🇺🇸

Houston, Texas, United States

Green Bay Oncology at Saint Vincent Hospital

🇺🇸

Green Bay, Wisconsin, United States

Saint Vincent Hospital Cancer Center Green Bay

🇺🇸

Green Bay, Wisconsin, United States

Cancer Center of Western Wisconsin

🇺🇸

New Richmond, Wisconsin, United States

CoxHealth South Hospital

🇺🇸

Springfield, Missouri, United States

Saint John's Hospital - Healtheast

🇺🇸

Maplewood, Minnesota, United States

New Ulm Medical Center

🇺🇸

New Ulm, Minnesota, United States

North Memorial Medical Health Center

🇺🇸

Robbinsdale, Minnesota, United States

Lakeview Hospital

🇺🇸

Stillwater, Minnesota, United States

Park Nicollet Clinic - Saint Louis Park

🇺🇸

Saint Louis Park, Minnesota, United States

Kansas City NCI Community Oncology Research Program

🇺🇸

Prairie Village, Kansas, United States

Cancer Center of Kansas-Wichita Medical Arts Tower

🇺🇸

Wichita, Kansas, United States

Via Christi Regional Medical Center

🇺🇸

Wichita, Kansas, United States

Associates In Womens Health

🇺🇸

Wichita, Kansas, United States

Riverside Methodist Hospital

🇺🇸

Columbus, Ohio, United States

Bronson Methodist Hospital

🇺🇸

Kalamazoo, Michigan, United States

Saint John Macomb-Oakland Hospital

🇺🇸

Warren, Michigan, United States

Lake Huron Medical Center

🇺🇸

Port Huron, Michigan, United States

Ascension Saint Mary's Hospital

🇺🇸

Saginaw, Michigan, United States

Greenville Health System Cancer Institute-Spartanburg

🇺🇸

Spartanburg, South Carolina, United States

Marie Yeager Cancer Center

🇺🇸

Saint Joseph, Michigan, United States

Ridgeview Medical Center

🇺🇸

Waconia, Minnesota, United States

Michiana Hematology Oncology PC-Westville

🇺🇸

Westville, Indiana, United States

University of Virginia Cancer Center

🇺🇸

Charlottesville, Virginia, United States

University of Hawaii Cancer Center

🇺🇸

Honolulu, Hawaii, United States

University of Colorado Hospital

🇺🇸

Aurora, Colorado, United States

Michigan Cancer Research Consortium NCORP

🇺🇸

Ann Arbor, Michigan, United States

Saint Joseph Mercy Hospital

🇺🇸

Ann Arbor, Michigan, United States

University of Michigan Comprehensive Cancer Center

🇺🇸

Ann Arbor, Michigan, United States

Hurley Medical Center

🇺🇸

Flint, Michigan, United States

The Hospital of Central Connecticut

🇺🇸

New Britain, Connecticut, United States

Smilow Cancer Hospital Care Center at Saint Francis

🇺🇸

Hartford, Connecticut, United States

University of Chicago Comprehensive Cancer Center

🇺🇸

Chicago, Illinois, United States

NorthShore University HealthSystem-Evanston Hospital

🇺🇸

Evanston, Illinois, United States

Sudarshan K Sharma MD Limited-Gynecologic Oncology

🇺🇸

Hinsdale, Illinois, United States

Carle Cancer Center

🇺🇸

Urbana, Illinois, United States

Elkhart Clinic

🇺🇸

Elkhart, Indiana, United States

Elkhart General Hospital

🇺🇸

Elkhart, Indiana, United States

Michiana Hematology Oncology PC-Mishawaka

🇺🇸

Mishawaka, Indiana, United States

IU Health La Porte Hospital

🇺🇸

La Porte, Indiana, United States

Michiana Hematology Oncology PC-South Bend

🇺🇸

South Bend, Indiana, United States

Michiana Hematology Oncology PC-Plymouth

🇺🇸

Plymouth, Indiana, United States

Memorial Hospital of South Bend

🇺🇸

South Bend, Indiana, United States

McFarland Clinic PC - Ames

🇺🇸

Ames, Iowa, United States

South Bend Clinic

🇺🇸

South Bend, Indiana, United States

Cancer Center of Kansas - Dodge City

🇺🇸

Dodge City, Kansas, United States

Cancer Center of Kansas - Chanute

🇺🇸

Chanute, Kansas, United States

Cancer Center of Kansas - El Dorado

🇺🇸

El Dorado, Kansas, United States

Cancer Center of Kansas - Fort Scott

🇺🇸

Fort Scott, Kansas, United States

Cancer Center of Kansas-Independence

🇺🇸

Independence, Kansas, United States

University of Kansas Cancer Center

🇺🇸

Kansas City, Kansas, United States

Cancer Center of Kansas - Newton

🇺🇸

Newton, Kansas, United States

Cancer Center of Kansas-Kingman

🇺🇸

Kingman, Kansas, United States

Cancer Center of Kansas-Liberal

🇺🇸

Liberal, Kansas, United States

Minnesota Oncology Hematology PA-Woodbury

🇺🇸

Woodbury, Minnesota, United States

Saint Luke's East - Lee's Summit

🇺🇸

Lee's Summit, Missouri, United States

Carolinas Medical Center/Levine Cancer Institute

🇺🇸

Charlotte, North Carolina, United States

Summa Akron City Hospital/Cooper Cancer Center

🇺🇸

Akron, Ohio, United States

Cleveland Clinic Akron General

🇺🇸

Akron, Ohio, United States

Women and Infants Hospital

🇺🇸

Providence, Rhode Island, United States

Greenville Health System Cancer Institute-Faris

🇺🇸

Greenville, South Carolina, United States

Chattanooga's Program in Women's Oncology

🇺🇸

Chattanooga, Tennessee, United States

Green Bay Oncology Limited at Saint Mary's Hospital

🇺🇸

Green Bay, Wisconsin, United States

Bay Area Medical Center

🇺🇸

Marinette, Wisconsin, United States

Holy Family Memorial Hospital

🇺🇸

Manitowoc, Wisconsin, United States

Froedtert and the Medical College of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

Saint Luke's Hospital of Kansas City

🇺🇸

Kansas City, Missouri, United States

Research Medical Center

🇺🇸

Kansas City, Missouri, United States

Iowa-Wide Oncology Research Coalition NCORP

🇺🇸

Des Moines, Iowa, United States

University of New Mexico Cancer Center

🇺🇸

Albuquerque, New Mexico, United States

Iowa Methodist Medical Center

🇺🇸

Des Moines, Iowa, United States

Medical Oncology and Hematology Associates-Des Moines

🇺🇸

Des Moines, Iowa, United States

Medical Oncology and Hematology Associates-Laurel

🇺🇸

Des Moines, Iowa, United States

Mercy Medical Center - Des Moines

🇺🇸

Des Moines, Iowa, United States

Iowa Lutheran Hospital

🇺🇸

Des Moines, Iowa, United States

Baptist Health Lexington

🇺🇸

Lexington, Kentucky, United States

University of Wisconsin Hospital and Clinics

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath